For information only. Not investment advice, a recommendation, an offer or a solicitation, and without regard to any recipient’s objectives or circumstances. Figures come from third-party sources believed reliable but not guaranteed, and market data may be delayed. Past performance is not a reliable indicator of future results. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() Cboe Global Markets Inc.CBOE US · Financials · USD Current price$357.69as of Nov 19, 2026 Summary
Analyst consensusStrong Buy 3Buy 2Hold 11Strong Sell 215 analysts 3-year price (USD)Factor profileMulti-factor score 98 / 100 Market data
Business descriptionCboe Global Markets (CBOE) is one of the world's largest exchange holding companies, operating the largest options exchange in the U.S. (~30% market share). Its proprietary VIX and SPX options franchises are irreplaceable competitive assets. Competitive moat
Recent developments
Investment risks / red flags
Financials
Classification
|
Last updated: Aug 11, 2026
Current price: $357.69 · Nov 19, 2026· USD
CFRA Ratingbuy
TBI Multi Score98
Theme Exposure
Related Peers
Loading graph…
Factor Profile (Spider Chart)
TBI ModelPrice Chart (TradingView)
Symbol: CBOEBusiness description
Cboe Global Markets (CBOE) is one of the world's largest exchange holding companies, operating the largest options exchange in the U.S. (~30% market share). Its proprietary VIX and SPX options franchises are irreplaceable competitive assets.
Competitive moat
- Exclusive SPX Listing Rights: Cboe holds exclusive U.S. listing rights for S&P 500 index options (SPX) through December 31, 2032 (non-exclusive through 2033), anchoring its highest-margin, most liquid derivatives franchise.
- Proprietary VIX Franchise: Sole owner of the VIX volatility methodology and its futures/options complex, making Cboe the de facto global benchmark for equity volatility — a brand and liquidity moat peers cannot replicate.
- 0DTE Options Leadership: Same-day-expiry (0DTE) SPX options hit a record 66.2% of total SPX volume in July 2026, a structural growth vector concentrated almost entirely on Cboe's platform.
- Diversified, High-Margin Revenue Base: Options, North American equities, Europe/APAC, global FX, and futures segments all posted Y/Y growth in Q2 2026, reducing reliance on any single geography or asset class.
- Fortress Balance Sheet: Net debt/EBITDA of roughly 0x gives flexibility for buybacks, dividends, and further international expansion.
Recent developments
- Record 0DTE and Mini-SPX Volumes (July 2026 volumes, reported 08/05/2026): Mini-SPX (XSP) options set a monthly ADV record of 238K contracts including a record 0DTE ADV of 138K contracts; multi-listed options ADV rose 28.4% Y/Y and index options ADV rose 34.0% Y/Y.
- Sell-Side Price Target Hikes (early August 2026): Following the Q2 beat, BofA raised its target to $330 (from $307) and Piper Sandler to $321 (from $295), citing higher 2026/2027 EPS estimates.
- Q2 2026 Earnings Beat & Guidance Raise (07/31/2026): Record net revenue of $731.6M (+25% Y/Y), adjusted diluted EPS of $3.56 (+45% Y/Y); management raised full-year 2026 organic net revenue growth guidance to the mid-to-high teens.
Investment risks / red flags
- ⚠️ SPX/Index Options Concentration: A large share of earnings flows through the SPX options franchise; any erosion of the S&P 500's benchmark status, or loss of listing exclusivity beyond 2032/2033, would be a structural threat to the moat.
- ⚠️ 0DTE Regulatory Scrutiny: Regulators continue to debate whether explosive growth in zero-days-to-expiry options (~66% of SPX volume) contributes to intraday "flash crash" risk; a regulatory cap or margin change could curb Cboe's fastest-growing revenue stream.
- ⚠️ European PFOF Ban: The EU's 2026 ban on payment-for-order-flow could disrupt retail liquidity that Cboe's European equities/derivatives business depends on.
- ⚠️ Volatility Dependence: Trading volumes and transaction revenue remain sensitive to swings in market volatility; a prolonged low-volatility regime could compress results.
- ⚠️ Valuation: Shares trade at ~25x trailing earnings, leaving less room for multiple expansion if growth decelerates.
Market Data
Source: mkts.io · Nov 19, 2026, 22:01 UTC
Key Metrics
P/E (TTM)25.46
P/E (Fwd)23.00
Dividend0.96%
Beta0.36
52W High$379.76
52W Low$227.15
Analyst Consensus
3
2
11
2
Strong Buy3Buy2Hold11Strong Sell215 analysts
Consensus Target$360.27
+0.7% upside
Calendar Events
Next EarningsOct 30, 2026
Ex-DividendNov 30, 2026
Dividend DateDec 15, 2026
Financials
Revenue$5.28B
Rev Growth19.00%
Earnings Growth43.20%
Gross Margin53.88%
Op Margin36.43%
Profit Margin28.05%
EBITDA$2.03B
ROA11.84%
ROE27.39%
Rev/Share$50.45
Total Cash$2.66B
Total Debt$1.58B
D/E Ratio26.63
Free Cash Flow$848.63M
Op Cash Flow$2.63B
Current Ratio1.60
Forward Estimates
| Period | EPS Est | Rev Est |
|---|---|---|
| 0q | 3.61 | $726.29M |
| +1q | 3.81 | $743.33M |
| 0y | 14.41 | $2.89B |
| +1y | 15.50 | $3.00B |
Earnings
Quarterly EPS
4Q2025
Est: 2.953.06Beat
1Q2026
Est: 3.383.70Beat
2Q2026
Est: 3.493.56Beat
3Q2026
Est: 3.433.63Beat
Annual
2022
Rev $1.74BEarn $234.10M
2023
Rev $1.92BEarn $757.50M
2024
Rev $2.07BEarn $761.00M
2025
Rev $2.43BEarn $1.09B
Rating Changes
| Date | Firm | Action | To |
|---|---|---|---|
| Nov 2, 2026 | Barclays | main | Overweight |
| Nov 2, 2026 | TD Cowen | main | Buy |
| Nov 2, 2026 | Wells Fargo | main | Equal-Weight |
| Oct 30, 2026 | RBC Capital | main | Sector Perform |
| Oct 28, 2026 | JP Morgan | main | Underweight |
| Oct 14, 2026 | Wells Fargo | main | Equal-Weight |
